4th State MedicalRegenerative · Technology
Leadership

Scientists and operators building the platform.

4th State Medical is led by a scientific founder with decades of regenerative research and an executive team with commercial and sales depth across medical technology.

Scientific Founder
1
Executive Team
2
Publications
520+
Scientific
01

Scientific leadership.

Dr. Jonathan Lakey, PhD, MSM
Chief Scientific Officer · Scientific Founder

Professor Emeritus of Surgery and Biomedical Engineering at UC Irvine with 520+ peer-reviewed publications and 50+ invited book chapters spanning diabetes, islet transplantation, stem cell technologies, and biomaterials. Co-inventor of the Edmonton Protocol — the landmark treatment for Type-1 diabetes via islet transplantation. Founder & CSO of a pet stem cell therapy company; co-founder of a stem cell banking and disease-differentiation transplant company. Globally recognized leader in stem cell and exosome-derived therapeutic products.

  • Professor Emeritus, UC Irvine
  • 520+ peer-reviewed publications
  • Co-inventor, Edmonton Protocol
  • Multiple issued & provisional patents
Executive
02

Executive team.

Mike Branzuela
Chief Executive Officer

Chief Executive Officer leading corporate strategy, commercial development, and capital formation across the 4th State Medical platform.

Greg Gasparini
Chief Sales Officer

Chief Sales Officer leading commercial sales strategy, distribution and channel partnerships, and clinical account development across the portfolio.

Join the Team
Open scientific and operating roles.

We selectively recruit scientists, engineers, and operators aligned with disciplined regenerative science. Reach out through the contact page.

Contact us →
Scientific Collaboration
Propose a research partnership.

Investigators, clinical centers, and industry partners are welcome to propose collaborations aligned with the BioSignal research agenda.

Submit a proposal →
NoticeSome biographical fields — including headshots, additional executives, and advisors — are in the process of being confirmed for public listing and will be added as materials are approved.